Página 1 dos resultados de 84 itens digitais encontrados em 0.002 segundos
Resultados filtrados por Publicador: Molecular Diversity Preservation International

Production of Chitooligosaccharides and Their Potential Applications in Medicine

Aam, Berit B.; Heggset, Ellinor B.; Norberg, Anne Line; Sørlie, Morten; Vårum, Kjell M.; Eijsink, Vincent G. H.
Fonte: Molecular Diversity Preservation International Publicador: Molecular Diversity Preservation International
Tipo: Artigo de Revista Científica
Publicado em 27/04/2010 EN
Relevância na Pesquisa
27.25%
Chitooligosaccharides (CHOS) are homo- or heterooligomers of N-acetylglucosamine and D-glucosamine. CHOS can be produced using chitin or chitosan as a starting material, using enzymatic conversions, chemical methods or combinations thereof. Production of well-defined CHOS-mixtures, or even pure CHOS, is of great interest since these oligosaccharides are thought to have several interesting bioactivities. Understanding the mechanisms underlying these bioactivities is of major importance. However, so far in-depth knowledge on the mode-of-action of CHOS is scarce, one major reason being that most published studies are done with badly characterized heterogeneous mixtures of CHOS. Production of CHOS that are well-defined in terms of length, degree of N-acetylation, and sequence is not straightforward. Here we provide an overview of techniques that may be used to produce and characterize reasonably well-defined CHOS fractions. We also present possible medical applications of CHOS, including tumor growth inhibition and inhibition of TH2-induced inflammation in asthma, as well as use as a bone-strengthener in osteoporosis, a vector for gene delivery, an antibacterial agent, an antifungal agent, an anti-malaria agent, or a hemostatic agent in wound-dressings. By using well-defined CHOS-mixtures it will become possible to obtain a better understanding of the mechanisms underlying these bioactivities.

Anti-Inflammatory Activity of Chitooligosaccharides in Vivo

Fernandes, João C.; Spindola, Humberto; de Sousa, Vanessa; Santos-Silva, Alice; Pintado, Manuela E.; Malcata, Francisco Xavier; Carvalho, João E.
Fonte: Molecular Diversity Preservation International Publicador: Molecular Diversity Preservation International
Tipo: Artigo de Revista Científica
Publicado em 28/05/2010 EN
Relevância na Pesquisa
27.25%
All the reports to date on the anti-inflammatory activity of chitooligosaccharides (COS) are mostly based on in vitro methods. In this work, the anti-inflammatory activity of two COS mixtures is characterized in vivo (using balb/c mice), following the carrageenan-induced paw edema method. This is a widely accepted animal model of acute inflammation to evaluate the anti-inflammatory effect of drugs. Our data suggest that COS possess anti-inflammatory activity, which is dependent on dose and, at higher doses, also on the molecular weight. A single dose of 500 mg/kg b.w. weight may be suitable to treat acute inflammation cases; however, further studies are needed to ascertain the effect upon longer inflammation periods as well as studies upon the bioavailability of these compounds.